Crossmark

Potential use of clinical polygenic risk scores in psychiatry – ethical implications and communicating high polygenic risk

Crossref DOI link: https://doi.org/10.1186/s13010-019-0073-8

Published Online: 2019-02-27

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Palk, A. C. https://orcid.org/0000-0002-6798-0985
Dalvie, S.

de Vries, J.

Martin, A. R.

Stein, D. J.
License Information

Text and Data Mining valid from 2019-02-27
More Information

Article History

Received: 23 November 2018

Accepted: 14 February 2019

First Online: 27 February 2019

Ethics approval and consent to participate

: Not applicable

: Not applicable

: In the past 3 years DJS has received research grants and/or consultancy honoraria from Biocodex, Lundbeck, Servier, and Sun. The other authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.